Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia

27 May 2016

Abstract excerpt

// George S. Laszlo 1 , Kimberly H. Harrington 1 , Chelsea J. Gudgeon 1 , Mary E. Beddoe 1 , Matthew P. Fitzgibbon 2 , Rhonda E. Ries 1 , Jatinder K. Lamba 3 , Martin W. McIntosh 2 , Soheil Meshinchi 1, 4, 5 , Roland B. Walter 1, 6, 7 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA 2 Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA 3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Immune Cell Function and Interaction
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27248327
DOI: 10.18632/oncotarget.9674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemiaPMID 27248327Read ↗

The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemiaSemantic proximity Read ↗

Novel CD33 antibodies unravel localization, biology and therapeutic implications of CD33 isoforms.Semantic proximity Read ↗

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.Semantic proximity Read ↗

Targeting CD33 for Acute Myeloid Leukemia TherapySemantic proximity Read ↗

Targeting CD33 for acute myeloid leukemia therapy.Semantic proximity Read ↗

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330.Semantic proximity Read ↗

Differences in CD33 Intensity Between Various Myeloid NeoplasmsSemantic proximity Read ↗

CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agentsSemantic proximity Read ↗

Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemiaSemantic proximity Read ↗

Gemtuzumab ozogamicin in acute myeloid leukemia.Semantic proximity Read ↗

Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot studySemantic proximity Read ↗

CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.